Header Logo

Connection

George Hofmeyr to HIV Infections

This is a "connection" page, showing publications George Hofmeyr has written about HIV Infections.
Connection Strength

1,348
  1. Effects of injectable contraception with depot medroxyprogesterone acetate or norethisterone enanthate on estradiol levels and menstrual, psychological and behavioral measures relevant to HIV risk: The WHICH randomized trial. PLoS One. 2024; 19(3):e0295764.
    View in: PubMed
    Score: 0,251
  2. Behavioral effects of different contraceptive methods and HIV acquisition: an ancillary study of the ECHO randomized trial. Reprod Health. 2021 Sep 29; 18(1):192.
    View in: PubMed
    Score: 0,211
  3. Interpretation, communication, and mechanisms of associations between injectable contraception and HIV risk. Lancet HIV. 2015 Sep; 2(9):e365.
    View in: PubMed
    Score: 0,138
  4. Hypothesis: amenorrhea-inducing contraception may reduce HIV acquisition risk. Contraception. 2014 Dec; 90(6):615-6.
    View in: PubMed
    Score: 0,130
  5. Hormonal contraception for women exposed to HIV infection. Cochrane Database Syst Rev. 2014 May 20; (5):CD009741.
    View in: PubMed
    Score: 0,127
  6. Management of breech presentation in areas with high prevalence of HIV infection. Int J Gynaecol Obstet. 2004 Dec; 87(3):272-6.
    View in: PubMed
    Score: 0,066
  7. High Levels of Pretreatment HIV-1 Drug Resistance Mutations Among South African Women Who Acquired HIV During a Prospective Study. J Acquir Immune Defic Syndr. 2022 10 01; 91(2):130-137.
    View in: PubMed
    Score: 0,055
  8. Maternal weight and birth outcomes among women on antiretroviral treatment from conception in a birth surveillance study in Botswana. J Int AIDS Soc. 2021 06; 24(6):e25763.
    View in: PubMed
    Score: 0,052
  9. Effects of Depot Medroxyprogesterone Acetate, Copper Intrauterine Devices, and Levonorgestrel Implants on Early HIV Disease Progression. AIDS Res Hum Retroviruses. 2020 08; 36(8):632-640.
    View in: PubMed
    Score: 0,048
  10. Reducing mother-to-child transmission of HIV. S Afr Med J. 2000 Apr; 90(4):322, 324.
    View in: PubMed
    Score: 0,048
  11. Changes to the World Health Organization guideline on hormonal contraceptive eligibility for women at high risk of HIV: South African perspective and response. S Afr Med J. 2018 Jul 25; 108(8):629-631.
    View in: PubMed
    Score: 0,042
  12. HIV-1 disease progression in immune-competent HIV-1-infected and breastfeeding mothers participating in the ANRS 12174 clinical trial in Burkina Faso, South Africa, Uganda and Zambia: a cohort study. BMJ Open. 2018 04 05; 8(4):e019239.
    View in: PubMed
    Score: 0,041
  13. Demographic, clinical and behavioural determinants of HIV serostatus non-disclosure to sex partners among HIV-infected pregnant women in the Eastern Cape, South Africa. PLoS One. 2017; 12(8):e0181730.
    View in: PubMed
    Score: 0,040
  14. Preventing perinatal infections. BMJ. 1997 Jul 26; 315(7102):199-200.
    View in: PubMed
    Score: 0,040
  15. Extended pre-exposure prophylaxis with lopinavir-ritonavir versus lamivudine to prevent HIV-1 transmission through breastfeeding up to 50 weeks in infants in Africa (ANRS 12174): a randomised controlled trial. Lancet. 2016 Feb 06; 387(10018):566-573.
    View in: PubMed
    Score: 0,035
  16. Copper containing intra-uterine devices versus depot progestogens for contraception. Cochrane Database Syst Rev. 2010 Jun 16; (6):CD007043.
    View in: PubMed
    Score: 0,024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.